Overview

Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This research is a Randomized, double-blind, risperidone-controlled, multicenter clinical study. Chinese subjects with Ischemic Schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Treatments:
Iloperidone
Risperidone